CCCC logo

C4 Therapeutics (CCCC) Shareholders Equity

Annual Shareholders Equity

$215.99 M
-$30.13 M-12.24%

December 1, 2024


Summary


Performance

CCCC Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCCCCbalance sheetmetrics:

Quarterly Shareholders Equity

$215.99 M
-$26.67 M-10.99%

December 31, 2024


Summary


Performance

CCCC Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCCCCbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

CCCC Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.2%-11.0%
3 y3 years-44.6%-11.0%
5 y5 years+292.9%-11.0%

CCCC Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-44.6%at low-44.6%at low
5 y5-year-44.6%+292.9%-48.1%+238.5%
alltimeall time-44.6%+292.9%-48.1%+238.5%

C4 Therapeutics Shareholders Equity History

DateAnnualQuarterly
Dec 2024
-
$215.99 M(-11.0%)
Dec 2024
$215.99 M(-12.2%)
-
Sep 2024
-
$242.66 M(-1.8%)
Jun 2024
-
$247.06 M(-4.3%)
Mar 2024
-
$258.28 M(+4.9%)
Dec 2023
$246.11 M(-14.9%)
$246.11 M(+13.9%)
Sep 2023
-
$216.02 M(-7.6%)
Jun 2023
-
$233.71 M(-11.0%)
Mar 2023
-
$262.47 M(-9.3%)
Dec 2022
$289.23 M
$289.23 M(-9.1%)
Sep 2022
-
$318.18 M(-7.7%)
DateAnnualQuarterly
Jun 2022
-
$344.59 M(-5.5%)
Mar 2022
-
$364.53 M(-6.4%)
Dec 2021
$389.61 M(+38.8%)
$389.61 M(-2.3%)
Sep 2021
-
$398.78 M(-4.2%)
Jun 2021
-
$416.43 M(+57.9%)
Mar 2021
-
$263.70 M(-6.1%)
Dec 2020
$280.79 M(-350.8%)
$280.79 M(-280.1%)
Sep 2020
-
-$155.92 M(-226.0%)
Jun 2020
-
$123.78 M(-210.6%)
Dec 2019
-$111.96 M(+40.4%)
-$111.96 M
Dec 2018
-$79.75 M
-

FAQ

  • What is C4 Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for C4 Therapeutics?
  • What is C4 Therapeutics annual shareholders equity year-on-year change?
  • What is C4 Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for C4 Therapeutics?
  • What is C4 Therapeutics quarterly shareholders equity year-on-year change?

What is C4 Therapeutics annual stockholders equity?

The current annual shareholders equity of CCCC is $215.99 M

What is the all time high annual shareholders equity for C4 Therapeutics?

C4 Therapeutics all-time high annual stockholders equity is $389.61 M

What is C4 Therapeutics annual shareholders equity year-on-year change?

Over the past year, CCCC annual stockholders equity has changed by -$30.13 M (-12.24%)

What is C4 Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of CCCC is $215.99 M

What is the all time high quarterly shareholders equity for C4 Therapeutics?

C4 Therapeutics all-time high quarterly stockholders equity is $416.43 M

What is C4 Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, CCCC quarterly stockholders equity has changed by -$26.67 M (-10.99%)